Immuron (ASX:IMC) reveals positive anti-diarrhoea vaccine results

Immuron (IMC) is surging on the ASX today after revealing some encouraging progress in the development of a treatment for diarrhoea.

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.